Updates are available Correction dated 2020-07-22
Click to view Correction: https://doi.org/10.1245/s10434-020-08871-2
-
Authors
Farley, C. R.
Perez, M. C.
Soelling, S. J.
Delman, K. A.
Harit, A.
Wuthrick, E. J.
Messina, J. L.
Sondak, V. K.
Zager, J. S.
Lowe, M. C.
- License Information
-
More Information
Article History
Received: 18 May 2019
First Online: 26 February 2020
Change Date: 22 July 2020
Change Type: Correction
Change Details: C.R. Farley and M.C. Perez contributed equally to this publication and are co-first authors. J.S. Zager and M.C. Lowe contributed equally to this publication and are co-corresponding authors.
Disclosure
: Dr. Sondak is a compensated consultant for Array, Bristol Myers Squibb, Genentech Roche, Merck, Novartis, Pfizer, Polynoma, and Regeneron. J. S. Zager is a compensated consultant for Array Biopharma, Amgen, Castle Biosciences, Merck, Philogen. Medical advisory board for Delcath Systems and Merck. Research Novartis, Amgen, Delcath, Philogen, Provectus. Speakers Bureau Array, Sun Pharma. Clinical Trial participation Merck and EMD Serono/Pfizer.
